Overview

A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B501

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.
Phase:
Phase 4
Details
Lead Sponsor:
Pacira Pharmaceuticals, Inc
Collaborator:
Registrat-Mapi
Treatments:
Bupivacaine